NEVVI Medicare utilization intelligence

← back

MARKUS, MAURICEM.D. NPI 1073590782 Clinician

Hematology-Oncology · COLORADO SPRINGS, CO

Specialty Hematology-Oncology — from billed Medicare claims
Trained JS WEILL MEDICAL COLLEGE, CORNELL UNIVERSITY — medical school, self-reported to CMS
In practice about 25 years since medical school (class of 2001, self-reported to CMS)
Location COLORADO SPRINGS, CO · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 63 codes billed · 43,606 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
ROCKY MOUNTAIN CANCER CENTERS LLP
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-10

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1453 Injection, fosaprepitant, 1 mg
J0185 Injection, aprepitant, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J1437 Injection, ferric derisomaltose, 10 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
80053 Blood test, comprehensive group of blood chemicals
J1626 Injection, granisetron hydrochloride, 100 mcg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J2469 Injection, palonosetron hcl, 25 mcg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
A9595 Piflufolastat f-18, diagnostic, 1 millicurie
84153 Psa (prostate specific antigen) measurement, total
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
96413 Administration of chemotherapy into vein, 1 hour or less
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
84443 Blood test, thyroid stimulating hormone (tsh)
84439 Thyroxine (thyroid chemical), free
93793 Anticoagulant management of patient taking warfarin
83521 Measurement of immunoglobulin light chains
96375 Injection of additional new drug or substance into vein
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
82784 Gammaglobulin (immune system protein) measurement
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J3489 Injection, zoledronic acid, 1 mg
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
85055 Reticulated (young) platelet measurement
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
84165 Protein measurement, serum
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
82728 Ferritin (blood protein) level
J3475 Injection, magnesium sulfate, per 500 mg
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
83540 Iron level
83550 Iron binding capacity
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96417 Administration of additional new drug or substance into vein, 1 hour or less
83735 Magnesium level
36591 Collection of blood sample from implanted device
71260 Ct scan of chest with contrast
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
74177 Ct scan of abdomen and pelvis with contrast
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
96415 Administration of chemotherapy into vein, each additional hour
J1200 Injection, diphenhydramine hcl, up to 50 mg
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
J7030 Infusion, normal saline solution , 1000 cc
96523 Irrigation of implanted venous access drug delivery device
96361 Infusion into a vein for hydration, each additional hour
96411 Administration of additional new drug or substance into vein using push technique
J3490 Unclassified drugs
78816 Nuclear medicine study whole body with ct scan
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
99442 Telephone medical discussion with physician, 11-20 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.